| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.9M | — | -2.9% |
| Cost of Revenue | $1.2M | — | -17.7% |
| Gross Profit | $7.7M | — | -0.0% |
| R&D Expense | $3.2M | — | -2.4% |
| SG&A Expense | $5.5M | — | +9.7% |
| Operating Income | -$8.4M | — | -14.8% |
| Pre-tax Income | $1.5M | — | +114.9% |
| Income Tax | $4K | — | -20.0% |
| Net Income | $1.5M | — | +114.8% |
| EPS (Basic) | $0.03 | — | +107.7% |
| EPS (Diluted) | $0.03 | — | +107.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.6M | +176.7% | +335.0% |
| Accounts Receivable | $5.2M | -20.5% | -4.4% |
| Inventory | $3.8M | +22.8% | -9.2% |
| Current Assets | $68.1M | +111.3% | +171.5% |
| Total Assets | $71.0M | +100.9% | +148.0% |
| Current Liabilities | $11.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.5M | — | -44.0% |
| Capital Expenditures | $141K | — | -81.3% |
| Investing Cash Flow | -$141K | — | +80.3% |
| Financing Cash Flow | $42.4M | — | +337.5% |
| Free Cash Flow | -$6.6M | — | -26.0% |
| +0.3% |
| Long-term Debt | $33.1M | +0.1% | +4.4% |
| Total Liabilities | $58.2M | -15.9% | -7.7% |
| Stockholders' Equity | $12.8M | +137.8% | +137.3% |